Board of Directors

Members of the Board of Directors (BoD):

Five BoD and Executive Council Members (in alphabetical order):

President: Dr. Tai-Ping Fan

Tai-Ping Fan
Tai-Ping Fan

Born in Taiwan, I received my PhD from University of London and moved to University of Cambridge in 1986. Capitalizing on my immunopharmacology background, I set up Angiogenesis & Chinese Medicine Laboratory and embarked on a quest to transform the art of TCM into a rigorous evidence-based science of healthcare. From clinically effective herbs, we have been investigating the cellular and molecular mechanisms of their compounds in the prevention and treatment of angiogenic diseases e.g. cancer, diabetic retinopathy and chronic wounds. With an international team of researchers from the US, the Netherlands and Hong Kong, we were the first to report in Circulation (2004) that the differential effects of ginseng on vascular pathophysiology was due to the specific make-up of pro- and anti-angiogenic ginsenosides in different types of ginseng. Working closely with research institutes, pharmaceutical companies, philanthropists and government agencies, I aspire to create a Cambridge Centre of Ethnopharmacology and Natural Medicine for promoting international collaborations of TCM and other traditional medicines.

My outreach activities include http://www.phar.cam.ac.uk/research/fan/outreach

▪ AAAS Science magazine Special Supplement on “The Art and Science of Traditional Medicine” (4 parts)

▪ A speech “Health and Healing Through Evidence-based Applications of Traditional Medicine” at United Nations Headquarters in July 2015

Return to top

Past President: Prof. De-an Guo

De-an Guo
De-an Guo

I am currently working as a chair professor and director of Shanghai Research Center for TCM Modernization, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, P.R. China. I received my Bachelor degree in 1983 and master degree of pharmacognosy in 1987 and Ph.D. in 1990. Worked as a postdoctoral fellow in Texas Tech University, USA from 1993 to 1996, I mainly pursued research on biosynthesis and biotransformation of natural products. My social concurrent posts include expert committee member of Chinese Pharmacopoeia since 2000 the Chairman of Natural Medicine Expert Committee; Expert Committee Member of United States Pharmacopeia, President of Society for TCM Analysis, WFCMS; Board member of Society for Medicinal Plant Research (GA); Associate editor, editor or editorial board members of 11 international journals such as “Journal of Ethnopharmacology”. I had been pursuing phytochemical analysis, metabolism and biological studies on Chinese herbal drugs for a long period with over 430 papers (among which 260 are in SCI cited journals) published in the past 20 years with over 3000 citations. I received the National Outstanding Youth Grant of NSFC in 1999. I have supervised 12 postdoctoral fellows and over 45 Ph.D. students.

Return to top

Treasurer: Prof. Peter Hylands

Peter Hylands
Peter Hylands

Professor Hylands is a pharmaceutical chemist and started his career with academic appointments in the University of Strasbourg, as a Royal Society European Fellow, and in the University of London. His special research interest has always been natural products in medicine. He joined the commercial world in 1988 as Director of Chemistry and then Research Director of biopharmaceutical companies in the UK and the USA. He has consulted for the United Nations and Commonwealth Science Council. He has worked or collaborated with institutions on every continent in natural medicines and natural product research and development. He serves on a number of boards and advisory boards and is currently Head of the Department of Pharmacy, King’s College London and Joint Head of the Institute of Pharmaceutical Science, King’s College London. He teaches organic chemistry, including the application of spectroscopy to structural studies, and pharmacognosy, for undergraduate and postgraduate courses. His current research emphasises the application of chemometrics and emerging biotechnologies to the problems of standardisation and quality control of plant medicines. He now has a research group in the Centre for Natural Medicines Research, King’s College London of which he is Director.

Return to top

Secretary-General: Prof. Clara Lau

Clara Lau
Clara Lau

Professor Clara Lau is the Associate Director of the Institute of Chinese Medicine at The Chinese University of Hong Kong. She also serves as the Associate Director of the Partner State Key Laboratory of Phytochemistry and Plant Resources in West China (CUHK). She has a courtesy appointment as Associate Professor at the School of Chinese Medicine, CUHK and has served as Deputy Program Director/Program Director (2005-2015) of a part-time MSc in Chinese Medicines and Herbal Drugs. With BPharm and PhD in Pharmacy (Pharmacognosy) from King’s College London, University of London, United Kingdom, she has a continuous interest in medicinal plants (western herbals and traditional Chinese herbal medicines) and has over 20 years’ experience in natural products research. Her major research areas include investigations on potential anti-cancer and anti-diabetic activities of natural products. She has published over 200 refereed journal articles. She currently serves as member of ChP-USP Advisory Group on Monographs for Traditional Chinese Medicine Ingredients and Products; Deputy Secretary General of The Consortium for Globalization of Chinese Medicine; Executive Committee member of Modernized Chinese Medicine International Association; Advisor for Chinese Medicine Council of Hong Kong on Registration of Proprietary Chinese Medicines; and Editorial Board member of journals “Phytomedicine” and “Scientific Reports”.
Return to top

President-Elect: Prof. Aiping Lu

Aiping Lu
Aiping Lu

Professor Lu Aiping is Chair Professor & Dean of School of Chinese Medicine, Hong Kong Baptist University, and Chair Professor in Shanghai University of Traditional Chinese Medicine. Prof. Lu is also the recipient of the Distinguished Young Scholar in National Science Foundation of China (NSFC) in 2007. Besides, he also as Member of Medical Advisory Committee of National Natural Science Foundation of China (NSFC), Member of Chinese Pharmacopoeia Commission and Vice-Chairman, Terminology of Traditional Chinese Medicine Sub-Committee, China National Committee for Terms in Sciences and Technologies (CNCTST). Also he has been appointed as Head & Spokesperson of the China Delegation, International Organization for Standardization Technical Committee on TCM (ISO/TC249) since 2009. His research interests mainly focus on the translational research in Chinese medicine, including pharmacological and clinical evaluation on rheumatoid arthritis with traditional Chinese medicine pattern diagnosis and interventions, and development of new drugs based on Chinese medicines. Also he is actively involving the research on the standardization of Chinese medicine and strategic plan research for Chinese medicine development in China. Prof Lu has published more than 30 books and over 500 articles, including 200 articles in SCI journals such as Nature Medicine, Nature Communication, Biomaterials, and Briefings in Bioinformatics.

Return to top

Eight BoD Members (in alphabetical order):

Past President: Prof. Rudolf Bauer

Rudi Bauer

Professor Rudolf Bauer studied pharmacy at University of Munich and graduated as Ph.D. in 1984; 1993-2002 associate professor at the Institute of Pharmaceutical Biology, University of Düsseldorf; since 2002 professor of pharmacognosy at University of Graz, Austria, 2004 Head of Institute of Pharmaceutical Sciences at University of Graz; since 2008 head of TCM Research Center Graz – medicinal plant research. Guest professor at School of Chinese Materia Medica, Beijing University of Chinese Medicine; Guangxi Botanical Garden of Medicinal Plants and Institute of Guangxi Medicinal Plants, Nanning; Institute of Medicinal Plant Development, China Academy of Medical Sciences, Beijing; Chengdu University of TCM; Heilongjiang University of CM, Harbin; Changchun University of CM. Recipient of Egon-Stahl-Award of the Society for Medicinal Plant and Natural Product Research (GA) and Norman Farnsworth Excellence in Botanical Research Award. Associate Editor in Chief of Chinese Journal of Natural Medicines and World Journal of Traditional Chinese Medicine (WJTCM). Member of the expert group on Chinese herbs of the European Pharmacopoeia. President of the Society for Medicinal Plant and Natural Products Research (GA) for six years, founding president of GP-TCM Research Association, and currently president of the International Society for Ethnopharmacology. Long experience in natural product chemistry; ca. 340 scientific publications.

Return to top

Mr. Abraham Chan

Abraham Chan
Abraham Chan

I am the founder and Chairman of PuraPharm. PuraPharm has dedicated itself to the modernization and internationalization of traditional Chinese medicine (TCM). It is a leading company engaged in the R&D, production, sale of concentrated Chinese Medicine granules (CCMG) products. PuraPharm has its TCM research & production facilities in Guangxi, China which complies with the PRC Good Manufacturing Practice (GMP) standards and the Australia’s Therapeutic Goods Administration (TGA) standards. PuraPharm is one of the six companies licensed to make and sell CCMG in China and is China’s top five exporters of proprietary Chinese medicine.
I am responsible for the overall strategic planning and operations of the Group’s business. I also lead the Group’s research development and technological development functions. I have over 25 years of extensive experience in Chinese medicine and healthcare products. I graduated from the University of Toronto in Canada with a Bachelor’s Degree in Applied Sciences in 1982. I was accredited as a chartered engineer in the United Kingdom in October 1989 and was accredited as a professional engineer in Ontario, Canada in January 1989.

Return to top

Prof. Pierre Duez

Pierre Duez

PhD in Pharmaceutical Sciences (Toxicology), Pierre Duez heads a teaching and research department in the Université de Mons (Faculty of Medicine and Pharmacy); he is teaching Pharmacognosy, Pharmacology, Nutrition and bibliographical tools, both in theory and practice. His laboratory has access to the main chromatographic and spectroscopic techniques and welcomes Belgian and foreign PhD students. Specialized in the study of natural products, in bioguided fractionation of medicinal plant extracts and in the analysis of phytodrugs, herbal nutritional supplements and food constituents, the team concentrates on the elucidation of DNA repair modulators from food and medicinal plants. Pierre Duez is member of the European Pharmacopoeia TCM working party, of the Belgian Commission of Pharmacopoeia, of the Belgian Commission for Registration of Herbal Medicines. He is active in development cooperation with Algeria, Argentina, Germany, Burkina Faso, France, Uganda, UK, DR Congo, PR China, Rwanda, Madagascar, Vietnam. Member of the GP-TCM consortium, he is currently Board Member and Chair of the Pharmacology & Toxicology Interest Group for the GP-TCM RA. He is (co-)supervisor of 19 defended theses, co-editor of 1 book, co-author of 8 book chapters, 142 scientific papers, 1 report for the European Development Fund and 246 communications in national and international meetings. He has organized the 2015 GP-TCM RA meeting in Mons, Belgium.

Return to top

Prof. Thomas Efferth

Thomas Efferth
Thomas Efferth

Professor Dr. Prof. h. c. mult. Thomas Efferth is chair of the Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz, Germany. He is biologist by training (Technical University of Darmstadt, Germany). His doctoral thesis was completed at the German Cancer Research Center (DKFZ), Heidelberg, Germany (1990). Dr. Efferth was awarded the Ludolf-Krehl-Prize of the Southwest German Association for Medicine (1991), the Willmar-Schwabe-Award of the German Society for Medicinal Plant Research (2006), the citizen medal of the City of Heidelberg, Germany (2008), the CESAR Award for Translational Oncology (2011), and the SCENTEDdrop Award on medicinal and flagrant herbs (2015). He headed a research group for Pharmaceutical Biology at DKFZ (2005-2009) and was associate professor (apl) at the University of Heidelberg (2007-2009). In 2009, he took over the Chair of Pharmaceutical Biology (full professorship) at the Johannes Gutenberg University, Mainz. Furthermore, he is honorary professor at the Northeast Forestry University, Harbin, and at the Zhejiang Chinese Medical University, Hangzhou, China. Moreover, he is visiting professor at the Zhejiang University of Science and Technology, Hangzhou, China.
Thomas Efferth has published >440 PubMed-listed papers and in peer-reviewed journals in the field of cancer research, pharmacology, and natural products (Hirsch-factor: 60; citation rate: >15,000) and a textbook on ‘Molecular Pharmacology and Toxicology’ (Springer Publisher; 2006). He holds 7 patents. The scientific results were communicated in over 180 oral presentation and invited lectures and over 150 poster presentations at national and international conferences and meetings. He is editor-in-chief, co-editor, associate editor and editorial board member of 30 scientific journals and scientific advisory board member of the German Pharmaceutical Society and several other institutions. Seven of his former lab members promoted to associate or assistant professors. The focus of Dr. Efferth’s research is on tumor pharmacology, pharmacogenomics, and the development of novel options for treatment and diagnosis of cancer. A major topic is research on chemical entities from natural sources.

Return to top

Prof. Monique Simmonds

Monique Simmonds

I have 30 years experience of research into different aspects of plant and fungal chemistry with an emphasis on the economic value of natural products, including quality control of medicinal plants. I am involved in the development of appropriate methods for the quality control of plants entering the trade and work with government bodies and industry. I am an international member of advisory committee for Hong Kong Dept. of Health, Pharmacopoeia, a member of the British Pharmacopoeia Commission, Dept of Health, UK and Chairman Elect, Expert Advisory Group Herbal and Complementary Medicines (Dept of Health, UK). Although my research is mainly on the chemistry of plants I have close research interactions with those developing DNA methods especially new methods that can link identification with quality. Within TCM I have worked closely with colleagues to support the collection of relevant material that can be used to authenticate plants and fungi used in TCM. I have over 360 publications and have supervised 37 PhD students. (www.kew.org)

Return to top

Prof. Rob Verpoorte

Rob Verpoorte

Emeritus Professor of Pharmacognosy at Natural Products Laboratory, IBL, Leiden University, pharmacist from origin, I have worked on many aspects of medicinal plants and plant secondary metabolism. In the past years the application of systems biology approaches using metabolomics to study activity and quality of medicinal plants and the role of secondary metabolism in plants has been my major field of interest. I published more than 740 papers and 4 books in the field of natural products.

Return to top

Prof. Vivian Taam Wong

Vivian Taam Wong

Current Service to Professional Organizations:

  • Hon Professor, School of Chinese Medicine, HKU
  • Vice President, Modernized Chinese Medicine International Association
  • Board of Director, GP-TCM Research Association
  • HK Coordinator, Consortium for Globalization of Chinese Medicine
  • Council Member, Chinese Association of Integrative Medicine
  • Key Past Appointments:

  • Public Health Specialist, Policy & Research, Population Health & Nutrition, The World Bank
  • Chairman, Committee on Safe Motherhood, International Federation of Gynecology & Obstetrics
  • Member of various Committees under World Health Organization
  • Consultant on Health Project IV & VI in China for the World Bank
  • Chief Executive, Hospital Authority, HK
  • Hon Advisor in Integrative Medicine, Hospital Authority, HK
  • Hon Senior Advisor to Dean of Medical Faculty, the University of HK
  • President, HK Association for Integration Chinese-western Medicine

    I have been on editorial boards of 6 journals, and published >120 peer-reviewed papers. I set up the unique HK-wide Research Ethics Committee system & standards enabling multicentre trials as well as the high quality network of Chinese Medicine Centres for Training and Research in each district in HK. She is now steering education, research and knowledge transfer to support collaboration among CM and western medicine practitioners.

    Return to top

    Dr. Qihe Xu

    Qihe Xu

    Dr. Qihe Xu, GP-TCM RA Life Member & Newsletter Co-editor, Co-Director of King’s Centre for Integrative Chinese Medicine (CICM), Senior Lecturer in Renal Medicine, Pharmacology Admissions Tutor and Organiser of MSc/MRes Pharmacology Projects at King’s College London (KCL). My research has been funded by National Natural Science Foundation of China, International Society of Nephrology, Royal Society, Kidney Research UK, British Heart Foundation, as well as UK, US and EU governments. In 2009-2012, I coordinated the FP7 GP-TCM Project. In 2012-2014, I served as Vice President & Vice Secretary-General of the GP-TCM RA. I earned my MBBS, MD and PhD from Xinxiang Medical College, Beijing Medical University and the General Hospital of the Chinese PLA, respectively. My past honours included a meritorious medal from the Chinese PLA, a national award for scientific & technological advances in China, a scholarship and a fellowship from the International Society of Nephrology and a Courtesy Associate Fellowship of the US National Institutes of Health. Other past experiences included Secretary-General, Chinese Students & Scholars Association in the UK, President of the Chinese Life Scientists Society in the UK and Founder Vice-President of the Academy of Life Sciences for Chinese in the UK, etc.

    Return to top

  • Comments are closed.